BMC Complementary and Alternative Medicine (May 2008)

Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes

  • Zamora Eslaen,
  • Fraser Yeiny,
  • Young Ronald,
  • McGrowder Donovan A,
  • Morrison Errol Y,
  • Gordon Lorenzo A,
  • Alexander-Lindo Ruby L,
  • Irving Rachael R

DOI
https://doi.org/10.1186/1472-6882-8-21
Journal volume & issue
Vol. 8, no. 1
p. 21

Abstract

Read online

Abstract Background Yoga has been shown to be a simple and economical therapeutic modality that may be considered as a beneficial adjuvant for type 2 diabetes mellitus. This study investigated the impact of Hatha yoga and conventional physical training (PT) exercise regimens on biochemical, oxidative stress indicators and oxidant status in patients with type 2 diabetes. Methods This prospective randomized study consisted of 77 type 2 diabetic patients in the Hatha yoga exercise group that were matched with a similar number of type 2 diabetic patients in the conventional PT exercise and control groups. Biochemical parameters such as fasting blood glucose (FBG), serum total cholesterol (TC), triglycerides, low-density lipoprotein (LDL), very low-density lipoproteins (VLDL) and high-density lipoprotein (HDL) were determined at baseline and at two consecutive three monthly intervals. The oxidative stress indicators (malondialdehyde – MDA, protein oxidation – POX, phospholipase A2 – PLA2 activity) and oxidative status [superoxide dismutase (SOD) and catalase activities] were measured. Results The concentrations of FBG in the Hatha yoga and conventional PT exercise groups after six months decreased by 29.48% and 27.43% respectively (P Conclusion The study demonstrate the efficacy of Hatha yoga exercise on fasting blood glucose, lipid profile, oxidative stress markers and antioxidant status in patients with type 2 diabetes and suggest that Hatha yoga exercise and conventional PT exercise may have therapeutic preventative and protective effects on diabetes mellitus by decreasing oxidative stress and improving antioxidant status. Trial Registration Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12608000217303